US tariff chaos, global headwinds hit pharma GCC hiring in India

Uncertainty surrounding US tariffs and global economic headwinds has tempered hiring in India's pharmaceutical and healthcare GCCs. Experts predict a 6-7% reduction in net talent addition this fiscal year as companies adopt a cautious approach. Despite this temporary slowdown, India remains a vital hub for R&D, with long-term growth prospects fueled by innovation and a large talent pool.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oS9pBix
via IFTTT